Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus
Sponsored by SCYNEXIS, Inc.
Active
$243.3K Funding
3 People
External
Related Topics
candidemia,
invasive candidiasis,
treatment regimens,
echinocandin,
ibrexafungerp
People
Jose Elizondo
(CD)
Medicine
﹒Research Program Administration Officer III
Martha Barron
(CD)
Medicine
﹒Research Program Administration Officer III
Tirdad Zangeneh
Co-Investigator (COI)
Medicine
﹒Professor
